Multiple Myeloma: Improved outlook for people with blood cancer

March 28, 2022

A Cancer Treatment Centers of America® (CTCA) Chicago patient shared the experience of her journey with multiple myeloma in an article published by Chicago Health. The article also features commentary from the patient’s physician, Dr. Syed Abutalib, Associate Medical Director of Hematologic Malignancies and Bone Marrow Transplant Program at CTCA® Chicago, on the number of new cases and deaths from Multiple Myeloma in the U.S. each year.

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.